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Conclusion: In VMAT of stage III lung cancer, AAA precision is 
adequate even in DIBH. In SBRT of stage I lung cancer, AAA 
overestimates target coverage, especially in DIBH. However, 
changing to the more correct Acuros for stage I SBRT may 
potentially facilitate a change in clinically prescribed dose. 
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Purpose or Objective: Monte Carlo-based treatment planning 
systems (TPS) are becoming as standard in radiation therapy, 
performing and reporting calculations in terms of the 
absorbed dose to medium (Dm). In addition, patient-specific 
QA techniques for IMRT and VMAT treatments have recently 
evolved from traditional dose distribution comparisons 
between calculations and measurements to 3D dose 
calculation and reconstruction on patient anatomy, enabling 
DVH-based comparisons. In order to perform previous 
calculations, commercial solutions have introduced collapsed 
cone algorithms, based in dose engines that report 
calculations in terms of the absorbed dose to water (Dw). 
Differences between Dm and Dw can lead to significant 
discrepancies in DVH comparisons. This study reports the 
discrepancies between Dm and Dw calculations applied to 
patient-specific prostate VMAT treatments. 
 
Material and Methods: VMAT treatments were delivered with 
a 6 MV Synergy (Elekta) machine. Plans were generated with 
Monaco 3.1 (Elekta). 3D dose calculations were performed 
with two systems: Mobius3D (Mobius Medical Systems) (M3D) 
and COMPASS (IBA Dosimetry) (CC). In addition, the second 
one is capable of reconstructing the dose from measurements 
(CR). Forty prostate treatments were analyzed, taking 10 
from each usual staging (hig-, intermediate- and low-risk) 
and 10 prostate bed treatments after prostatectomy. 
Parameters analyzed for PTVs were taken from ICRU-83 
recommendations. Normal tissue parameters were evaluated 
using QUANTEC constraints for rectum, bladder and femoral 
heads. 
 
Results: Mean differences for PTVs parameters with Dm 
calculations were -0.61%±0.71%, -0.04%±1.49% and 
0.08%±1.52% for CC, CR and M3D, respectively. For PTVs 
parameters with Dm calculations discrepancies were -
0.22%±0.50%, 0.36%±1.27% and 0.47%±1.28%. Mean 
differences for normal tissue and CC, CR and M3D 
comparisons, respectively, were: 0.38%±0.74%, 2.94%±1.31% 
and 2.12%±1.31% for Dm, and 0.38%±0.54%, 2.94%±1.20% and 
2.12%±1.40% for Dw in rectum; 0.16%±1.06%, -1.00%±1.11% 
and 0.16%±1.45% for Dm, and 0.10%±0.58%, -1.06%±0.78% and 
0.10%±1.12% for Dw in bladder; -1.42%±0.83%, -1.03%±2.04% 
and -1.57%±1.77% for Dm, and 0.28%±2.01%, 0.88%±2.45% and 
-0.07%±2.62% for Dw in femoral heads. 
 
Conclusion: Results were slightly better for Dw in femoral 
heads than Dm calculations. Remaining data were similar for 
both Dm and Dw. According AAPM TG-105, QA comparisons 
should be performed with the same criterion (Dw). 
 
EP-1566 
Influence of inner materials of rectal balloon on TPS 
calculation accuracy and dose distribution 
J. Koo
1Korea University, Department of Bio-Convergence 
Engineering, SEOUL, Korea Republic of 
1 
 
Purpose or Objective: If rectal balloon were not used in 
rectum cancer treatment, there is a lack of reproducibility of 
rectum shape on each treatment and irregularly inserted air 
inside the rectum cause inhomogeneity of density with 
surrounding tissue, which could be resulted in uncertainty of 
dose delivery. In this research, we estimated the accuracy of 
TPS(Treatment Planning System) dose calculation and actual 
dose, and compared dose distribution when homogeneity of 
rectum and surrounding tissue increases as inner materials of 
rectal balloon changes. 
 
Material and Methods: Cylindrical PMMA RPLGD phantom was 
used to measure dose at rectal wall and Air, water and PMMA 
were used as inner balloon materials. Total 12 plans(prostate 
and rectum cancer 3D-CRT(3 Dimensional Conformal 
Radiation Therapy) and IMRT(Intensity Modulated Radiation 
Therapy) plans with air, water, and PMMA balloons) were 
made using Varian Eclipse ver.8.9 to estimate influence of 
rectal balloon material on dose distribution. Each 16 glass 
dosimeters were located at rectum wall so that the point 
doses were compared with TPS. 
 
Results: As Homogeneity increase, Dose distribution was 
improved. As CT HU value of inner balloon material increase 
from 0(air) to 1000(water) and 1120(PMMA), Homogeneity 
Index(HI) and Conformity Index(CI) were increased about 20% 
and 5%, respectively. And considerable difference, between 
TPS and RPLGD reading, was measured with air balloon when 
water and PMMA balloons had less variation. 
 
 
 
